Avoca Quality Consortium Expands Membership to Product and Services Providers
The Avoca Quality Consortium announced its key initiatives for 2014.
The Avoca Quality Consortium announced its key initiatives for 2014, with a significant move to a change in its membership. That is it will offer Associate Consortium
Membership to companies that provide products and services in support of clinical development. This addresses what the Consortium believes will foster increased industry collaboration.
Other initiatives include:
- Develop a new standard for prequalification for niche providers. By facilitating the sharing of information, AQC hopes to increase efficiency and reduce the costs associated with prequalification.
- Continue AQC’s efforts to expand the Consortium’s resources and tools for leading practices for quality oversight: focus will be placed on developing principles and tools for Quality by Design and Risk Management.
- Conduct a benchmarking research effort to measure business practices and the status of quality management practices to gauge whether there has been improvement or decline in quality over the past two years.
- Kick-off a new collaboration with The Society of Clinical Research Sites (SCRS) to gather sites’ feedback and opinions about quality management practices and sites’ perceptions of sponsors and CROs.
- Launch an educational webinar series focused on quality management practices.
The Consoritum was founded in 2012 as an opportunity to bring sponsors and CROs together to accelerate the development of best practices and industry standards for proactive quality management. The Avoca Quality Consortium is led by The Avoca Group, Inc., a Princeton-based consulting firm.
Read the full release here.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
